The upregulation of compensatory survival pathways, specifically the HALLMARK_TNFA_SIGNALING_VIA_NFKB gene set involving high levels of FOS in LA fusion tumor cells, may explain this resistance. This evidence concerns the gene FOS and neoplasm.